Funds research on gene-edited NK cells and oncolytic viruses to enhance immunotherapy for glioblastoma by overcoming tumor-induced immune suppression.
NCI funds collaborative teams to develop therapies for adult glioblastoma that cross the blood-brain barrier, advancing novel or repurposed agents from preclinical studies into Phase 0/1 trials.
The Distinguished Scientist Award supports early-career scientists with independent research funding and a collaborative scientific community to advance understanding and treatment of malignant brain tumors.
Research Grants from the Southeastern Brain Tumor Foundation support researchers pursuing scientific studies and investigator-initiated clinical trials to advance the search for a cure for brain tumors.
Young Investigator Award supports early-career scientists pursuing innovative pediatric cancer research, including therapeutic target discovery, to advance better, safer treatments for children with cancer.
Discovery Grants from the American Brain Tumor Association support early-stage faculty testing high-risk brain tumor research ideas to generate preliminary data and potentially change diagnosis or treatment.